Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Condition(s):Heart FailureLast Updated:December 31, 2020Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Heart FailureLast Updated:December 31, 2020Active, not recruiting
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:November 24, 2020Not yet recruiting
Condition(s):Posttransplant Diabetes MellitusLast Updated:May 7, 2019Completed
Condition(s):Diabetic NephropathiesLast Updated:December 17, 2020Terminated
Condition(s):NephropathyLast Updated:July 30, 2019Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:June 16, 2020Not yet recruiting
Condition(s):Diabetes Mellitus Type 2Last Updated:May 15, 2018Completed
Condition(s):Atrial Fibrillation; Heart Failure; Obesity; Diabetes MellitusLast Updated:October 14, 2020Not yet recruiting
Condition(s):Non Alcoholic Fatty Liver DiseaseLast Updated:August 15, 2019Completed
Condition(s):Diabetes Mellitus, Type 2; Coronary Heart Disease; Arrythmia, CardiacLast Updated:April 7, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.